Reduction of Desipramine Cardiotoxicity and Prolongation of Survival in Rats With the Use of Polyclonal Drug-Specific Antibody Fab Fragments
- 1 September 1995
- journal article
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 26 (3) , 334-341
- https://doi.org/10.1016/s0196-0644(95)70083-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- 1992 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance SystemThe American Journal of Emergency Medicine, 1993
- Polyclonal amanitin-specific antibodies: production and cytoprotective properties in vitroBiochemical Pharmacology, 1993
- Drug-specific F(ab′)2 fragment reduces desipramine cardiotoxicity in ratsInternational Journal of Immunopharmacology, 1991
- Pretreatment with drug-specific antibody reduces desipramine cardiotoxicity in ratsLife Sciences, 1991
- Reversal of murine colchicine toxicity by colchicine-specific Fab fragmentsToxicology Letters, 1991
- Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.Circulation, 1990
- Pharmacokinetics and Toxicity of High-Dose Human α1-Acid Glycoprotein Infusion in the RatJournal of Pharmaceutical Sciences, 1987
- Tricyclic Antidepressant OverdoseJAMA, 1987
- Tricyclic Antidepressant PoisoningMedical Toxicology, 1986
- The hydrolysis of rabbit γ-globulin and antibodies with crystalline papainBiochemical Journal, 1959